Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

F
F De Filippi - Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
Fabbrini N - Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Fabre A - D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius
Fabris F - Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency
Fabris F - Prevalence of Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients Wwith Immune Thrombocytopenic Purpura (ITP)
Faden D2 - Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
Fadin M - Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study
  - A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
  - The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study
Fagnani F - Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study
Fagon JY - Elevated Gas6 Plasma Levels in Patients with Severe Sepsis
Fahmy RG - Blockade of Microvascular Endothelial Cell Replication, Migration, Tubule Formation, Matrix Angiogenesis and Retinal Neovascularization by siRNA Targeting the Basic Region-Leucine Zipper Transcription Factor cJun
Fahmy RG - Small Interfering RNA Targeting Human EGR-1 Inhibits FGF-2 Expression, Vascular Smooth Muscle Cell Growth and Intimal Thickening in Human Saphenous Vein Explants
Fahs SA - Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
  - Platelet-Derived Factor VIII (FVIII) Is Protected from Inhibitor Inactivation – A Potential Approach for Gene Therapy of Hemophilia A with Inhibitors
Fahs S - Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Fain O - Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
  - Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers
Fainboim H - Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content
Faioni EM - Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions
  - Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
  - Electrostatic Properties of Naturally Occurring Protein C Mutants by Computational Analysis
Falanga A - The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma
  - ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
  - Parallel Changes in Procoagulant Activity and Proangiogenic Capacity of Breast Cancer and Leukaemia Cells Exposed to All Trans Retinoic Acid (ATRA)
Falaschi F - Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
Falati S - Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Falciani M - MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
  - C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
  - Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
  - Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
  - Thrombophilia in Patients with Spinal Cord Injury
Falcinelli E - Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes
Falcinelli E - Deficiency of Matrix Metalloproteinase-2 (MMP-2) Impairs Platelet-Dependent Haemostasis in Mice
Falco A - Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
  - Determinants of Platelet Activation in Alzheimer's Disease
Falet H - The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Falet H - The WIP-WASp Complex Modulates Platelet Signaling and Function
Fan Q-s - Carrier Detection and Prenatal Diagnosis on Hemophilia
Fang Y - Carrier Detection and Prenatal Diagnosis on Hemophilia
Fang J - Modulating Murine Platelet Function by Expressing Integrin aIIbb3 Locked-In Its High Affinity State
Fang Y - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Fang J - Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
Faradji A - Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
  - Use of Helixate®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance
Faradz S - Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism
Farah RA - Combined Deficiency of Factor V and Factor VIII: Compound Heterozygosity For Two Novel Truncating Mutations in ERGIC53/LMAN1
  - Prenatal Diagnosis in a Lebanese Family with Severe Factor VII Deficiency
Farías C - Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke
Fard P - Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A
Fareed J - Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
  - Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin
Fareed D - Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin
Fareed J - Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin
Fareed D - Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
Fareed J - Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
  - Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay
  - Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia
Fareed D - Synthetic Anti-Xa Drugs but not Fondaparinux Can Be Used for Surgical and Interventional Anticoagulation
Fareed J - Synthetic Anti-Xa Drugs but not Fondaparinux Can Be Used for Surgical and Interventional Anticoagulation
Fareed J - Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
  - Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
  - Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
Fareed J - Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients
  - Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
  - Protamine Sulfate Is Capable of Neutralizing Bacterial Core Polysaccharide Derived Sulfaminoheparosans
  - Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications
  - FcgRIIa Platelet Polymorphism in Asian Indians: Its Association with Development of Heparin Induced Thrombocytopenia
  - Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Fareed D - Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
Fareed J - Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
  - Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
  - Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
Fareed D - Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
Fareed J - Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
  - Comparative Antithrombotic Effects of an Ultra Low Molecular Wight Heparin (Oligo H) and Enoxaparin in Animal Models of Arterial Thrombosis
Fareed J - Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications
Fareed J - Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
Fareed J - Down-Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate in Primates
Fareed D - Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
Fareed J - Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
Fareed J - Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin
Fareed J - Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
Fareed D - Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Fareed J - Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
  - Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests
  - Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
Fareed J - Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS
Fareed J - Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
  - Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications
  - Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
Fareed D - Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
Fareed J - Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
  - Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis
Fareed J - Tissue Factor Mediated Activation of Prothrombin Complex Concentrates and Its Inhibition by Anti-Thrombin Drugs
Fareed J - Modulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate. Results of a Study in Primates
Farge D - Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers
Faria F - Identification of New Secreted Proteins from Haementeria Depressa Leech Salivary Complexes by Transcriptomic and Proteomic Analysis
Faria F - Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor
Farías C - Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs
Farías CE - Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions
Farías C - Partial Purification of ADAMTS-13
  - Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family
Farid NA - Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
Farid NA - Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
Faridi A - Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Farina A - Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study
Farinaro E - Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study
Farndale RW - GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains
  - Differential Upregulation of Tissue Factor and Tissue Factor Pathway Inhibitor in Monocytes by Activated Platelets and Lipopolysaccharide
Farndale R - Regulation of Platelet Guanylyl Cyclase by Collagen: Evidence That Glycoprotein-VI Mediates Platelet Nitric Oxide Synthesis in Response to Collagen
Farndale W - Lipid Rafts Facilitate the Interaction of PECAM-1 with the GPVI-FcRg Complex in Human Platelets
Farndale RW - Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin
  - Differential Contribution of P2Y1 and P2Y12 ADP Receptors to GPVI-Mediated Phosphatidylserine Exposure on Platelets and Microparticles
  - GPVI-Dependent Binding of Murine Platelets to a Series of Triple-Helical Peptides Derived from Human Type III Collagen
  - Affinity Maturation of Blocking Human Antibodies Against Human Glycoprotein VI
  - Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1
  - Surfaces of Glycoprotein VI Involved in Collagen Binding and Receptor Clustering
  - Distinct Signals in Procoagulant Adherent Platelets Compared to Aggregated Platelets
Farndale RW2  - Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
Farouque HMO - Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study
Farrell DH - The Fibrinogen Aa R16C Mutation Results in Fibrinolytic Resistance
Farren T - Cocoa Beverage Shows Platelet Inhibition Activity, Depressing Platelet Activation Antigens CD61, CD62p and PAC1 and Extending the PFA 100 Closure Time
Farren T - Effective Venous Thromboembolic Risk Assessment in Pregnancy Allows Appropriate Thromboprophylaxis: a Prospective Outcomes Study
Farris D - Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
  - Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
Farrugia C - Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells
Fass DN - Quantitation of FVIII Antigen in Human Plasma
Fath J - Effectiveness of Recombinant Activated FVII (rFVIIa) for the Treatment of Severe Bleeding Episodes in Pediatric Patients
Fatini C - Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
  - Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
  - ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
  - Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
  - eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
  - MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
Fattorini A - LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®)
Fattorini L - Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System
Faulkner LJ - Thrombin Generation in Haemophilia A Patients Does Not Necessarily Correlate with Levels of Factor VIII Detected Using Standard Factor VIII Potency Assays: A Comparative Analysis of Pre- and Post-Infusion Patients Plasmas Using Fluorogenic and Clotting Thrombin Generation Tests
Faure V - Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins
Fauvel-Lafeve F - TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts)
Fauvel-Lafeve F - Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
Fauvel-lafeve F - Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Huvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion
Favaloro EJ - Towards Harmonisation of D-dimer Assays
  - How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective
  - Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
Favaloro JWC - Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
Favier R - HZF as a Candidate Gene for Gray Platelet Syndrome (GPS)
  - Protein Z and the Protein C System in Normal Pregnancies and Patients with Early Foetal Loss
Faxälv L - Video Enhanced Coagulation Assay (VECA) for Real Time Multi-Parameter Analysis of Blood Plasma Coagulation at Artificial Surfaces
Fay PJ - Factor VIII Residues 97–105 and 1954–1961 of the A1 and A3 Domains Represent an Inter-Subunit Interface
  - Activation of Factor VIII and Mechanisms of Cofactor Action
Fearnside M - Venous Thromboembolism and Spinal Surgery
Fearon WF - Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study
Featherstone J - Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease?
Federici AB - Long Term Prophylaxis of Bleeding Episodes in Patients with von Willebrand Disease: Efficacy and Safety of Factor VIII/von Willebrand Factor Concentrates
Federici A - Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
  - A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Federici AB - Treatment Options for von Willebrand's Disease
Federici A - Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
  - Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
  - Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
  - Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
  - Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
Federici F - In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
Federici A - The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
Federici AB - The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
  - Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect
Federici A - Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
  - Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
  - Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Federici AB - Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
Federici A - Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
Federico H - Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF)
Fedi S - Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
  - MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
  - Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
  - More Carotid Atherosclerosis in HCV Positive Italian Patients?
  - Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
  - Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
  - Thrombophilia in Patients with Spinal Cord Injury
Fedotkina, Yu, Goltsova K - Relation of Changes in D-dimer and Factor VIIa Levels after Treatment with Heparins to Clinical Outcomes of Unstable Angina
Fedotova I - Significance of Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Essential Hypertension
  - Relationship Between Oxidative Stress, Endothelial Injury and Coagulation: Activation in Advanced Chronic Heart Failure
Fefer P - Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results
Feijge MAH - P2Y12 Receptor Stimulation Prolongs Thrombin-Induced Calcium Responses and Procoagulant Activity Via Novel Signaling Pathways; Variable Effect of Clopidogrel Treatment
  - NF279 Inhibits the Contribution of P2X1 to Arteriolar Thrombosis Via Partial Agonism
  - Slower Translocation of Platelets at High Shear Rate without Increased Calcium Signals on Type 2B Recombinant Von Willebrand Factor
  - Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
  - Plasma Ecto-NTPDase Prevents Platelet P2X1 and P2Y12 Receptor Desensitization During Storage
  - Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation
Feilotter H - A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
Feindt P - Closure Times Determined with a Platelet Function Analyzer are Closely Correlated to the Mean Transvalvular Gradient in Patients with Aortic-Valve Stenosis
Feingold J - A Postmarketing Study of the Safety and Efficacy of ReFacto® in Haemophilia a Patients
Feistritzer C - PAR1- and S1P Pathway-Dependent Protection of Endothelial Barrier Integrity by Activated Protein C and Thrombin
  - Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
Feldman B - Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Feldman LJ - Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
Feldo M - Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD
Felici A - High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients
Felicissimo P - Extended Thromboprophylaxis with Fondaparinux (Arixtra®) after Major Orthopedic Lower Limb Surgery: The EXPERT Study
  - Use of Neuraxial Catheter for Anesthesia/Analgesia in Major Orthopedic Lower Limb Surgery Patients Treated With Prophylactic Doses of Fondaparinux (Arixtra®) in Routine Practice: The EXPERT Study
Feliú A - Platelet Aggregation and ATP Release Values in Children and Adults
  - Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
Fellows GA - Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years
Fenech M - FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals
Feng R - The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia
Feng Y - Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population
Fenneteau O - Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Fens D - Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Fenton II J - Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin
Fenyvesi T - Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin
  - Inhibition of Thrombin Generation by Warfarin
  - Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
Feraud O - Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation
Ferec C - Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
  - Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
  - Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients
Feren[ccaron]ak G - Factor XIII Val34Leu Polymorphism in Croatian Population
Fernandes AP - Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
  - Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
  - Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
  - Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients
  - Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment
  - Natural Anticoagulation Evaluation in Type 2 Diabetes
  - Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes
Fernandes JO - The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers
Fernández JA - Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
Fernandez JA - Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
Fernández G - Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents
Fernandez-Borja M - Protein Kinase A-dependent Clustering of Weibel-Palade Bodies in Endothelial Cells
Fernández JA - Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis
  - Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation
Ferrando F - Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
  - Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
Ferrante F - Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism
  - Validation of Laboratory Reference Standards for Clinical Use of INR-POC Devices: A Randomized Multicentre Exercise
  - Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System
  - Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Ferrara JD - Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins
Ferraresi P - Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
Ferrari E - D-Dimer and the Risk of Venous Thromboembolism in Medical Patients
Ferrari S - Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA
Ferraris VA - Gene Expression Abnormalities in Aspirin Hyper-responders
Ferraris SP - Gene Expression Abnormalities in Aspirin Hyper-responders
Ferraro L - Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy
Ferrazzi P - Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion
Ferreira MS - Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor
Ferreira MFR - Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
Ferrero S - Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
Ferrini S - Antiaggreganting Agents Do Not Influence the Sonoclot Profile
  - Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
  - Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
Ferris NML - Management of Anticoagulated Patients Undergoing Dental Treatment
Ferro D - Thrombus Growth Is Mediated by Gp91phox
Ferroni P - Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
Ferroni P - Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
Ferrucci L - Vitamin B6 Serum Level and Inflammation and in the InChianti Study
  - MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
  - Inflammatory Markers are Associated with the Abdominal Aortic Diameter
  - Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
  - Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
Fex B - Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
Feyen JHM - Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis
  - Elevation of Thrombotic Biomarkers Reveals the Prothrombotic State of Genetically Diabetic (db/db) and Obese (ob/ob) Mice
Feys HB - Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization
Ffrench PO - Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis
FH Herrmann - Haemophilia A in a Women Caused By Swyer-Syndrom and a Missense Mutation in Factor VIII Gene
Fibbi G - Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
Fichelson S - A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C
Fiedler F - Platelet Contractile Force and Clot Elastic Modulus Measured by Hemodyne Apparatus in Intensive Care Unit Patients: Identification of Patients with High Bleeding Risk
  - Predictive Value of ISTH DIC-Score and aPTT Waveform Analysis at Admission to the ICU
Figg N - Apoptotic Mechanisms Underlying High-Risk Plaque
Figueiredo MS - Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases
  - Are Discard Tubes Needed for PT and APTT Assays?
Figura S - Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells
  - Antiphospholipid Antibodies in Children – Reference Values in Healthy Controls and Frequency in Children with aPTT Prolongation, Thrombosis or Stroke
Fijnheer R - Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency
Filatov V - High Molecular Weight Fibrin Degradation Products Prevail over D-Dimer in Normal and Pathological Plasmas
Filatov V - The Use of DD2-DD6 Anti-D-Dimer MAb Pair For the Determination of Cross-linked Fibrin Degradation Products is a Possible Solution of D-Dimer Standard Problem
Filer K - Evaluation of a Commercial ELISA Based Assay for Factor XIII A
Filho CC - Systematic Review of Risk Factors for Venous Thromboembolism in Hospitalized Medical Patients and Recommendations for Prophylaxis Implementation by a Multidisciplinary Group
Filion ML - Fusion of the N-terminal Acidic Domain of Heparin Cofactor II to a1-PI M358R Increases the Rate of Thrombin Inhibition
Filippucci E - Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery
  - Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Filipuzzi L - Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®)
Filoni C - Thrombophilia in Patients with Spinal Cord Injury
  - Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
Finazzi S - D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
Finazzi G - ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
  - Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
  - Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Finch S - Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates
Findlay JBC - A Proteomics Approach for the Identification of Plasma Transglutaminase (FXIII) Substrates
  - Characterizing the Plasma Clot Proteome
Fink L - High Incidence and Transitory Nature of Acquired Resistance to Activated Protein C (aAPCR) in Patients with Multiple Myeloma
  - Tissue Factor and Factor VIIa Regulate Expression of Ets-1 in Prostate Cancer
Finn B - Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE)
Finocchi A - Thrombus Growth Is Mediated by Gp91phox
Fiore LD - The 80+ Hemorrhagic Cohort Study – Rates, Severity and Predictors of Major Hemorrhage in a Cohort of Anticoagulated Atrial Fibrillation Patients
Firbas C - Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge
  - The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia
  - Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation
Fisac Herrero R - Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
Fisac Martin M - Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
Fischer R - Home Treatment of Bleeding Episodes in Haemophiliacs With Inhibitors: Cost-Effectiveness of Three on-Demand Strategies in Germany
Fischer T - Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Fischer R - Use of Helixate®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance
Fischer A-M - Factor X Gene Mutations Affecting the Gla Domain of the Protein
Fischer E - Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease
Fischer D - Effect of Protein C and Activated Protein C on Alveolar Fibrin Deposition and Turnover in a Piglet Model of Septic Shock
Fischer K - Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A
Fischer H - Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia
  - Initial Treatment of Patients with Acute Deep-Vein Thrombosis Using 8.000 IU Bid Low-Molecular-Weight Heparin Certoparin – A 24 Months Follow Up
Fischer R - Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A
Fischer K - Late Prophylaxis for Severe Hemophilia: Effects of Prophylaxis Started in Adulthood
  - Childhood Acquired Hepatitis C Infection in Patients with Hemophilia: A Cohort Study
Fischer AM - Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells
  - Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model
Fish R - Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells
Fish RJ - The Activation of Mouse Fibroblasts by Antiphospholipid Antibodies Requires TLR2
Fishbein MC - Determinants of Plaque Instability in Atherosclerotic Vascular Disease
Fishel S - Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
Fisher WD - An Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study
Fisher R - Gene Expression Abnormalities in Aspirin Hyper-responders
Fissha M - High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study
  - Clopidogrel Effect on Platelet Reactivity in Patients with Stent Thrombosis: Results of the CREST Study
FitzGerald G - Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
  - Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
  - Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery
  - Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients:  Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Fitzgerald JR - Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation
Fitzgerald A - Unusual Haplotypic Associations with Marked GPIIIa Allelic Expression Bias in the Platelets of PlA2 Heterozygotes
Fitzgerald DJ - Unusual Haplotypic Associations with Marked GPIIIa Allelic Expression Bias in the Platelets of PlA2 Heterozygotes
FitzGerald G - The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients
  - Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials
Fitzmaurice DA - Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs – What Is the Truth?
Fkih M - Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Flan B - Nanofiltration's Contribution to Coagulation Factor Safety
  - Efficiency of TSE Elimination By Coagulation Factor Manufacturing Processes
Fläring A - Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome
Flaujac C - A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
Flaujac C - Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History
Flaujac C - Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation
  - Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists
Fleseriu I - Cardiomyogenic Differentiation Induced by in vitro Manipulation of Adult Stem Cells
Fletcher J - The Opposing Roles of Monocytes in Atherosclerosis
  - Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Elective Colorectal Surgery
  - Venous Thromboembolism and Spinal Surgery
Fletcher JP - Venous Thromboembolism Following Total Hip or Knee Arthroplasty
Fletcher J - The Circulating Progenitor in Intimal Hyperplasia: Could It Be the Fibrocyte?
Fletcher J - Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
  - Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis
Flierl U - Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
Flight S - Slow Lysis of Porcine Blood Clots Is Caused by Resistance of Plasminogen to Activation
Flipiak KJ - Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
  - Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
Floccard B - Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient
Flodgaard H - Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation
Flood VH - The Fibrinogen Aa R16C Mutation Results in Fibrinolytic Resistance
Flores MPA - Exploring New Molecules and Activities from Lonomia Obliqua Caterpillar Bristles Extract
Florian M - Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
  - Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Floriani I - The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma
Florian-Kujawski M - Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis
  - Tissue Factor Mediated Activation of Prothrombin Complex Concentrates and Its Inhibition by Anti-Thrombin Drugs
  - Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS
Florian-Kujawski M - Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
Florian-Kujawski M - Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
Florian-Kujawski M - Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
Florian-Kujawski M - Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
  - Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
Floros G - Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series
  - Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH)
Florquin S - Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
Flounders K - Anticoagulant Adverse Events in a Major City Hospital
Flynn M - Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura
Fogato L - Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Fok TF - The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production
  - The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice
Foka ZI - Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs
Foley JH - The Time Courses of Fibrin Formation, Prothrombin Activation and TAFI Activation in Normal and Factor VIII-Deficient Plasma
Folkeringa N - Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
Folkeringa N - Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
Follows GA - Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression
Folsom AR - Dietary Vitamin B6 and Folate Intake is Inversely Related to Risk of Developing Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)
Fondu P - A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
Fons P - Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Fons P - VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells
Fonseca Neto CP - Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
Fontaine S - High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
  - Protein Z and the Protein C System in Normal Pregnancies and Patients with Early Foetal Loss
Fontaine A - The Whole Blood Platelets Aggregation Test for HIT Diagnosis
Fontana P - The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers
Fontana G - Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
Fontana P - Aspirin and Clopidogrel Resistance: A Study on 96 Healthy Volunteers and Role of the P2Y12 H1/H2 Gene Polymorphism
Fontana V - Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder
Fontana G - Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions
Fontana V - Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP
Fontana P - Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers
Fontana V - ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’
Fontayne A - Development of a High-throughput ELISA Assay to Study Platelet Function
Fontayne A - Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody
Fontcuberta J - A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
  - The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism
  - Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
for the COAGFA Group  - The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
for the ETHICS Investigators  - Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
for the German ProTime Study Group: Völler, H  - A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System
Forastiero R - The Combination of LA with Antibodies to B2-Glycoprotein I (anti-B2GPI) and Prothrombin (anti-PT) Predicts a Higher Risk of Thrombosis
Forastiero R - A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI)
  - Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation
  - Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported
Forastiero R - Comparison Among the New Immunoassays with Monoclonal Antibody Calibration and Home-Made Methods for Testing the Antiphospholipid Antibody (APA) Family
Ford I - Evaluation of Aspirin Resistance in Peripheral Arterial Disease
Ford I - Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
Ford I - Coagulation Activation in Women with Hyperemesis Gravidarum
Ford E - Clinical and Laboratory Diagnosis of Heparin Induced Thrombocytopenia (HIT)
Ford I - The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication
  - Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Ford I - The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia
Forgan M - ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
Foroud T - Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains
Forslund M - Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms
Fortenberry YM - Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN)
  - Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin
Fortini P - Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Fortuna S - Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
Fossum T - The Utility of TGN 255 in a Model of Coronary Pulmonary Bypass and Simulated Mitral Valve Repair in the Dog
Foster TJ - A Comparison of the Effects of Shear Stress on the Interactions between Streptococcus sanguis and Staphylococcus aureus with Perfused Human Blood Platelets
  - Multiple Mechanisms for S. Aureus and S. Epidermidis Platelet Activation
  - Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation
Foster P - A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
Foster C - Antithrombotic Effects of SCH 205831: A Potent, Selective and Orally Active Antagonist of the PAR-1 Thrombin Receptor
Foti L - The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia
  - Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
Fouda M - Elevated Serum Nerve Growth Factor (NGF) Levels in Patients with Acute Leukemia and Lymphoma Especially with CNS Involvement
  - Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome
Fournier M - Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Fox ML - Clinical ‘Aspirin Resistance’ Is Associated with Increased Cyclooxygenase-Independent Platelet Activation
Fox E - The Relationship between Venous Thrombosis and Inflammation: A Systematic Review of Clinical Studies
Fox SC - Platelet Aggregation, Microparticle Formation and Platelet-Leukocyte Conjugate Formation Induced by Combinations of 5-HT and Epinephrine Are Inhibited by Sarpogrelate and BP-984
Fox SC - Involvement of P2Y1 and P2Y12 Receptors in Platelet Responses to Adenosine Diphosphate and Thrombin Receptor Activating Peptide
  - Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39
Fox KAA - Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
  - Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
Fox SC - Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y1 and P2Y12 Receptors
Fox ML - Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
Fox KAA - Bleeding Events with and without Thienopyridines in Patients with Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
Fraccarollo D - Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
  - Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
Frampton J - Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin
  - In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis
Francis JL - Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia
Francis JL - Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department
Francis JL - Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles
Francis CW - Elevated Platelet Count Increases the Risk of Thromboembolism during Outpatient Chemotherapy
Francis CW - Potentiation of Endothelial Nitric Oxide Synthase By Fibrinogen-bound IL-1b Requires aVb3
Francis JL - Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia
Francis JL - Heparin Platelet Factor 4 Antibody Formation in Patients Receiving Bivalirudin or Heparin for Off-Pump Coronary Artery Bypass Surgery
Francis JL - Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia
  - Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels
  - Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study)
Francis SE - Evidence of Partial P2Y12 Receptor Antagonism Despite Excess Clopidogrel in Mice
Francis CW - Risk Factors for Chemotherapy-Associated Venous Thromboembolism in a Prospective Observational Study: A Proposed Predictive Model
Francis JL - CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation
  - Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy
Franco RF - Are Discard Tubes Needed for PT and APTT Assays?
  - Influence of ABO Blood Group on the Collagen-Binding Assay
  - Retrospective and Prospective Analysis of the Incidence of Venous Thromboembolism in First-Degree Relatives of Factor V Leiden and Factor II G20210A Carriers
  - Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease
Franco RF - Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases
Franco RM - Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
Franco HA - Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
Franken T - Viral Safety of a Prothrombin Complex Concentrate (Octaplex®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration
Franks P - Venous Thromboembolism after Spinal Cord Injury: Incidence, Time Course and Associated Risk Factors in 6240 Adults and Children
Franow H - Patient Outcome during Oral Anticoagulant Therapy Using an Electronic Decision Support System
Frantz S - Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
Franz F - Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study)
Franz F - Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study
Franzoi M - Cerebral Sinovenous Thrombosis in Children
Frattani FS - Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor
Fredenburgh JC - Fibrinolytic Activity Is Enhanced after Major Orthopedic Surgery
Frederix K - Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice
  - ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice
Frederix K - Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice
Frederix K - A Hypercoagulable State in Myeloperoxidase Deficient Mice
Freedman J - The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation
  - Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin
  - Shear-Induced Platelet Apoptosis
  - Platelet Aggregation Independent of Von Willebrand Factor and Fibrinogen
Freedman JE - Differential Translocation of Syk, Akt, and Endothelial Nitric Oxide Synthase (eNOS) in Stimulated Platelets
Freedman J - Clearance of Procoagulant Platelet-Derived Microparticles from the Circulation of Rabbits
  - Regulation of in vivo Viability of Stored Platelet Concentrates by Platelet P-selectin Exposure and Glycoprotein Ib-alpha Downmodulation
Freeley M - Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes
Freeman MS - CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome?
  - Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation
Freeman R - Comparison of the Effectiveness of Protamine Sulphate and Polybrene in Neutralising Heparin in Patient Samples for Laboratory Testing
Freestone B - Increased Circulating Endothelial Cells in Acute Congestive Heart Failure: Comparison with von Willebrand Factor and Soluble E Selectin
Fregin A - Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
Frelinger AL - A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity
  - Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
Frelinger AL - Clinical ‘Aspirin Resistance’ Is Associated with Increased Cyclooxygenase-Independent Platelet Activation
Frelinger III - Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR
Frelinger III AL - Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms
French JK - ZPI Gene Mutations and Myocardial Infarction
Frere C - TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study
Frere C - Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting
Frere C - Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
Freson K - The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure
  - Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2)
Freson K - Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients
Fressinaud E - Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
  - WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
  - Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
  - Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product
  - Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
  - Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
  - Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
Freund M - Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
  - Cardiovascular Interventions and Surgery in Patients with Haemophilia and Von Willebrand Disease
  - Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times
Frey M - Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
Freyburger G - Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Friberg B - The Prevalence of Low von Willebrand Factor Activity and von Willebrand Disease Among Young Women with Bleeding Symptoms
Fribourg C - Distinct Roles of Basic Residues within the Heparin-Binding Exosite of Factor IX in the Assembly of the Factor X-Activating Complex
  - The Interface between the EGF2 Domain and the Protease Domain of Activated Factor IX Contributes to Cofactor Binding and Substrate Recognition
Friedrich W - Severe Bleeding Caused by a Platelet Defect Leading to Enhanced Binding of Coagulation Factor XI (FXI) to Platelet GPIb-alpha
Friedrichs B - Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice
Frigerio M - Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome
  - Regulation of Tissue Factor Expression in Human Platelet by Nitric Oxide
Friso S - Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
  - Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
Fritsch S - A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
  - Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures
Fritsche-Danielson R - Thrombin Inhibition with Melagatran Prevents Plaque Rupture in Apolipoprotein E Knockout Mice
Fritzen M - Exploring New Molecules and Activities from Lonomia Obliqua Caterpillar Bristles Extract
Fritzsche J - Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships
Froehlich JB - Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
  - Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
  - Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials
Froesner G - Antiviral Treatment of HCV Infected Young Haemophiliacs – An Update of 12 Years Experience
Frölke JPM - Transfusion of Blood Products in Trauma Patients with Lethal Hemorrhagic Shock
Frontoni R - Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study
Frontroth JP - Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
  - Platelet Aggregation and ATP Release Values in Children and Adults
Frossard M - Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up
Frost FJ - Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry
Frost C - Dose-Related Inhibition of Factor Xa in Healthy Subjects by Razaxaban, an Orally-Active Selective Factor Xa Inhibitor
Frostick SP - Fatal Vascular Outcomes Following Major Orthopedic Surgery
Frulla M - Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study
  - Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study
Fu J - Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion
Fu QH - In vitro Expression Study on the Antithrombin Gene C2759T (Leu99Phe) Mutation
Fu QH - Coagulation Factor X Deficiency Caused by a Mutant Signal Peptide that Affects Translocation to the Endoplasmic Reticulum
  - Platelet Antibody Analysis in Patients with Platelet Transfusion Refractoriness
  - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Fu B - Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases
Fuchs S - Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Fuchs I - Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up
Fuertbauer E - Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development
Fuhrmann J - Murine and Human ADAMTS13 Swap Mutants Shed a New Light on the Molecular Mechanism of the ADAMTS13-VWF Interaction
Fujii T - Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs
Fujii K - Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation
Fujii G - Contortrostatin: A Potent Inhibitor of Cancer Growth and Angiogenesis
Fujimoto M - Visual Evidence How Histidine-Rich Glycoprotein Promotes Fibrinolysis
  - Stellate Cells Produce ADAMTS13 in Human Liver
  - Visual Evidence How Histidine-Rich Glycoprotein Promotes Fibrinolysis
Fujimura Y - Stellate Cells Produce ADAMTS13 in Human Liver
  - Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Fukuda K - Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center
Fukuda A - Increased Levels of Hepatocyte Growth Factor in Patients with DIC
Fukuda T - Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats
  - Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Fukuda T - Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats
Fukui H - Stellate Cells Produce ADAMTS13 in Human Liver
Fukushima N - Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice
Fukutake K - Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency
  - Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B
Fukutake K - Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products
Fuller G - Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
Fuller GLJ - Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
Fuller N - Identification of the Multimerin 1 Binding Region within the C1 Domain of Factor V
Fulton J - Unique Patient Pathway for a Nurse-led DVT Clinic
Fumeaux T - Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications
Funahashi T - Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice
Fung S - Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Funiaková S - Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy
  - Plasma TFPI Levels in Patients Undergoing Regular Hemodialysis and Treated with Erythropoietin
Funk M - C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
Furber A - Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome
  - Are Diagnostic Algorithms for Suspected Pulmonary Embolism Applicable in French Emergency Departments?
  - Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
Furie BC - Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase
Furie B - Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase
  - Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury
Furie BC - Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury
  - Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis
Furie B - Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis
Furie Ba - Factor XI Deficient Mice Have Reduced Platelet Accumulation and Fibrin Deposition after Laser Injury
Furie BC - Calcium Mobilization Required for Firm Platelet Attachment is Dependent upon Both ADP and Thromboxane A2 during Thrombus Formation in a Living Mouse
Furie B - Calcium Mobilization Required for Firm Platelet Attachment is Dependent upon Both ADP and Thromboxane A2 during Thrombus Formation in a Living Mouse
  - Molecular Pathways Involved in Thrombus Formation in vivo after FeCl3 or Laser-Induced Injury
Furie BC - Molecular Pathways Involved in Thrombus Formation in vivo after FeCl3 or Laser-Induced Injury
Furie B - Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo
Furie BC - Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo
  - Role of the Bile Salt Dependent Lipase (BSDL) in Thrombus Formation: in vitro and in vivo Study
Furie B - Role of the Bile Salt Dependent Lipase (BSDL) in Thrombus Formation: in vitro and in vivo Study
Furie BC - Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Furie B - Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Furie, Br1,2  - Factor XI Deficient Mice Have Reduced Platelet Accumulation and Fibrin Deposition after Laser Injury
Furman MI - Clinical ‘Aspirin Resistance’ Is Associated with Increased Cyclooxygenase-Independent Platelet Activation
  - Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
  - A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity
  - Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms
Furmedge J - Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
  - Platelet Changes during Cardiopulmonary Bypass in Children
  - Developmental Haemostasis and Response to Heparin Therapy in Children
  - Heparin Monitoring During Haemodialysis in Children
  - Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis
  - Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children
  - Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU)
Furtado C - Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry
Furugohri T - Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Furugohri T - Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin
Furukoji E - Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Fuster JL - Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
Futers TS - CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome?